Eupraxia Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BEUTEL, GOODMAN & CO LTD. | 11/14/2025 | 4.06 M | $23.92 M | 100.00% | 12.12% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.35 M | $7.97 M | 100.00% | 4.03% |
| VIVO CAPITAL, LLC | 11/14/2025 | 1.35 M | $7.97 M | 100.00% | 4.03% |
| SCOTIA CAPITAL INC. | 11/14/2025 | 1.28 M | $7.25 M | -1.09% | 3.82% |
| GREAT POINT PARTNERS LLC | 11/14/2025 | 1.20 M | $7.08 M | 100.00% | 3.58% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2025 | 915.00 K | $5.40 M | 100.00% | 2.73% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 900.00 K | $5.31 M | 100.00% | 2.69% |
| ROYAL BANK OF CANADA | 11/14/2025 | 428.80 K | $2.53 M | 0.05% | 1.28% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2025 | 352.00 K | $2.08 M | 100.00% | 1.05% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 300.00 K | $1.77 M | 100.00% | 0.90% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 250.00 K | $1.48 M | 100.00% | 0.75% |
| UBS GROUP AG | 11/13/2025 | 95.76 K | $564.96 K | 155.36% | 0.29% |
| INGALLS & SNYDER LLC | 11/07/2025 | 59.10 K | $349.00 K | 58.87% | 0.18% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 45.58 K | $268.90 K | 262.90% | 0.14% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 40.10 K | $236.59 K | 0.75% | 0.12% |
| BANK OF MONTREAL /CAN/ | 11/13/2025 | 37.25 K | $219.43 K | 0.00% | 0.11% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 33.37 K | $196.90 K | 173.28% | 0.10% |
| GUARDIAN PARTNERS INC. | 11/13/2025 | 24.13 K | $147.41 K | 100.00% | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 21.40 K | $125.00 K | 100.00% | 0.06% |
| JPMORGAN CHASE & CO | 11/26/2025 | 16.47 K | $97.16 K | -12.02% | 0.05% |
| CIBC WORLD MARKET INC. | 11/06/2025 | 15.00 K | $88.36 K | 0.00% | 0.04% |
| INTEGRATED WEALTH CONCEPTS LLC | 11/14/2025 | 12.00 K | $70.80 K | 100.00% | 0.04% |
| TCI WEALTH ADVISORS, INC. | 10/14/2025 | 11.00 K | $64.90 K | 100.00% | 0.03% |
| TD WATERHOUSE CANADA INC. | 11/03/2025 | 9.60 K | $56.23 K | 0.00% | 0.03% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/14/2025 | 9.09 K | $51.59 K | 100.00% | 0.03% |
| NATIONAL BANK OF CANADA /FI/ | 11/14/2025 | 882 | $5.03 K | 20.82% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 9 | $53 | 100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| QUADRATURE CAPITAL LTD | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Eupraxia Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Eupraxia Pharmaceuticals Inc.. The most heavily invested institutionals were:
Beutel, Goodman & Co Ltd.: 4.06 M
Vivo Capital, LLC: 1.35 M
BALYASNY ASSET MANAGEMENT L.P.: 1.35 M
SCOTIA CAPITAL INC.: 1.28 M
GREAT POINT PARTNERS LLC: 1.2 M
Ally Bridge Group (NY) LLC: 915,000
38.27% of Eupraxia Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 12.81 M shares in the last 24 months. This purchase volume represents approximately $75.21 M in transactions.